Eversept Partners, LP Seres Therapeutics, Inc. Transaction History

Eversept Partners, LP

  • $1.32 Billion
  • Q2 2024

A detailed history of Eversept Partners, LP transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 418,208 shares of MCRB stock, worth $326,202. This represents 0.02% of its overall portfolio holdings.

Number of Shares
418,208
Previous 1,388,944 69.89%
Holding current value
$326,202
Previous $1.07 Million 71.84%
% of portfolio
0.02%
Previous 0.08%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.56 - $1.19 $543,612 - $1.16 Million
-970,736 Reduced 69.89%
418,208 $301,000
Q1 2024

May 15, 2024
SELL
$0.75 - $1.56 $273,445 - $568,766
-364,594 Reduced 20.79%
1,388,944 $1.07 Million
Q4 2023

Feb 14, 2024
SELL
$0.93 - $2.15 $557,086 - $1.29 Million
-599,018 Reduced 25.46%
1,753,538 $2.45 Million
Q3 2023

Nov 14, 2023
SELL
$2.33 - $5.07 $1.69 Million - $3.67 Million
-724,200 Reduced 23.54%
2,352,556 $5.6 Million
Q2 2023

Nov 08, 2023
BUY
$4.67 - $6.55 $2.52 Million - $3.54 Million
540,091 Added 21.29%
3,076,756 $14.7 Million
Q2 2023

Aug 14, 2023
BUY
$4.67 - $6.55 $2.52 Million - $3.54 Million
540,091 Added 21.29%
3,076,756 $14.7 Million
Q1 2023

Nov 08, 2023
BUY
$4.95 - $6.09 $1.66 Million - $2.04 Million
335,666 Added 15.25%
2,536,665 $14.4 Million
Q1 2023

May 15, 2023
BUY
$4.95 - $6.09 $1.66 Million - $2.04 Million
335,666 Added 15.25%
2,536,665 $14.4 Million
Q4 2022

Nov 08, 2023
BUY
$5.09 - $9.05 $1.35 Million - $2.4 Million
265,174 Added 13.7%
2,200,999 $12.3 Million
Q4 2022

Feb 14, 2023
BUY
$5.09 - $9.05 $1.35 Million - $2.4 Million
265,174 Added 13.7%
2,200,999 $12.3 Million
Q3 2022

Nov 08, 2023
SELL
$3.5 - $7.2 $3.99 Million - $8.21 Million
-1,140,931 Reduced 37.08%
1,935,825 $12.4 Million
Q3 2022

Nov 14, 2022
BUY
$3.5 - $7.2 $6.78 Million - $13.9 Million
1,935,825 New
1,935,825 $12.4 Million
Q3 2021

Nov 15, 2021
SELL
$5.46 - $22.6 $325,197 - $1.35 Million
-59,560 Closed
0 $0
Q2 2021

Nov 08, 2023
SELL
$18.46 - $24.36 $2.87 Million - $3.79 Million
-155,716 Reduced 72.33%
59,560 $1.42 Million
Q2 2021

Aug 16, 2021
SELL
$18.46 - $24.36 $2.87 Million - $3.79 Million
-155,716 Reduced 72.33%
59,560 $1.42 Million
Q1 2021

Nov 08, 2023
SELL
$17.66 - $28.92 $2.1 Million - $3.43 Million
-118,773 Reduced 35.56%
215,276 $4.43 Million
Q1 2021

May 13, 2021
SELL
$17.66 - $28.92 $2.1 Million - $3.43 Million
-118,773 Reduced 35.56%
215,276 $4.43 Million
Q4 2020

Nov 08, 2023
SELL
$23.25 - $37.73 $63.8 Million - $103 Million
-2,742,707 Reduced 89.14%
334,049 $8.18 Million
Q4 2020

Feb 16, 2021
BUY
$23.25 - $37.73 $7.77 Million - $12.6 Million
334,049 New
334,049 $8.18 Million

Others Institutions Holding MCRB

# of Institutions
93
Shares Held
46.7M
Call Options Held
119K
Put Options Held
466K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $96.8M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email